Overcoming time pressure and the global shortage of test kits and reagents, the 8-member Microbiology team from Gleneagles Hospital Hong Kong’s Clinical Laboratory has made in-house COVID-19 testing a reality, about two months after Hong Kong confirmed its first COVID-19 case.
Today, Gleneagles Hospital Hong Kong is capable of testing up to 150 COVID-19 samples daily in its laboratory. It uses two test platforms (POCT or point of care testing and PCR or polymerase chain reaction testing), to provide quality and efficient service to meet our patients’ needs.
Between end of March and end of May, the hospital tested more than 200 cases, while supporting the Hong Kong Government Department of Health’s Community Deep Throat Saliva Surveillance Programme with about 300 cases.
The team is ramping up the laboratory’s testing capacity to meet the anticipated surge in testing demand as the government prepares to open up its borders to businesses travellers with negative COVID-19 nucleic acid testing result certification.
By making COVID-19 testing available to our patients and the medical needs of our clinicians, Gleneagles Hospital Hong Kong is helping to stem the spread of the virus in the community. It is also keeping our hospital safe for our inpatients and frontline staff, ensuring that it continues to provide uninterrupted healthcare services during the COVID-19 pandemic.
Related Stories
Fortis Healthcare Hosts 1st Annual Neuro-conclave Mumbai 2026
Fortis Healthcare marked the successful conclusion of the 1st Annual Neuro-conclave Mumbai 2026, held on 21 and 22 March, showcasing the strength and integration of its neuroscience team.
IHH Malaysia Supports 10KM Category at Penang Bridge International Marathon
IHH Malaysia is the 10KM title sponsor for the upcoming Penang Bridge International Marathon 2026 (PBIM), encouraging individuals of all fitness levels to embrace a more active lifestyle.
IHH Singapore Recognised for Contributions to SGSHARE Initiative
IHH Singapore was recognised by Community Chest Singapore at the SG60 Appreciation Ceremony on 7 March 2026 for our contributions to the SGSHARE initiative.
Enhancing Patient Journeys at Pantai Hospital Melaka
Gleneagles Hong Kong Partners with Emerging Viral Diagnostics and Mannings to Expand Community Healthcare
Gleneagles Hong Kong has joined forces with Emerging Viral Diagnostics (EVDL) and Mannings to create an innovative community healthcare ecosystem, combining advanced diagnostics, healthcare expertise, and accessible community channels.
IHH Healthcare Malaysia supports 2,200km run to raise awareness for childhood cancer
IHH Healthcare is supporting a cross-country initiative aimed at raising awareness and funds for children battling cancer in Malaysia.
